ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
121.845,60
0,04%
S&P 500
5.337,71
0,88%
US Dollar vs BRL
5,2921
0,05%
Bitcoin
71.649,83
1,45%
Brent Oil
78,325
1,58%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Cancer Genetics Inc (CGIX)

  7. Cancer Genetics Inc (CGIX) Notícias

CGIX

Cancer Genetics (CGIX)

Cancer Genetics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:CGIX
DataHoraFonteTítuloCódigoCompanhia
15/05/202309:01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:CGIXCancer Genetics Inc
10/05/202309:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CGIXCancer Genetics Inc
04/05/202317:33Edgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeemed or Retired Securities (25)NASDAQ:CGIXCancer Genetics Inc
28/03/202307:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CGIXCancer Genetics Inc
24/03/202310:05Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CGIXCancer Genetics Inc
24/03/202309:35Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CGIXCancer Genetics Inc
19/01/202318:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CGIXCancer Genetics Inc
14/11/202218:46Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CGIXCancer Genetics Inc
15/08/202209:01Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:CGIXCancer Genetics Inc
14/06/202217:31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CGIXCancer Genetics Inc
03/06/202217:06Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:CGIXCancer Genetics Inc
12/05/202210:13Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:CGIXCancer Genetics Inc
29/04/202218:46Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:CGIXCancer Genetics Inc
11/04/202207:01Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CGIXCancer Genetics Inc
30/03/202208:39Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CGIXCancer Genetics Inc
14/02/202215:04Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CGIXCancer Genetics Inc
11/02/202209:37Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CGIXCancer Genetics Inc
29/12/202118:31Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:CGIXCancer Genetics Inc
18/05/202107:02Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CGIXCancer Genetics Inc
01/04/202120:02Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CGIXCancer Genetics Inc
31/03/202107:30GlobeNewswire Inc.Cancer Genetics and StemoniX Announce Merger ClosingNASDAQ:CGIXCancer Genetics Inc
25/03/202110:16Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CGIXCancer Genetics Inc
25/03/202110:15GlobeNewswire Inc.Cancer Genetics Announces Shareholder Approval of All Proposals in Connection with the Proposed Merger with StemoniXNASDAQ:CGIXCancer Genetics Inc
18/03/202109:30GlobeNewswire Inc.Cancer Genetics Announces Roland J. Carrillo, PhD as Vice President of Business DevelopmentNASDAQ:CGIXCancer Genetics Inc
12/03/202111:30GlobeNewswire Inc.Cancer Genetics to Present at the Annual 33rd ROTH ConferenceNASDAQ:CGIXCancer Genetics Inc
04/03/202118:15GlobeNewswire Inc.Cancer Genetics to Present at the H.C. Wainwright Global Life Sciences ConferenceNASDAQ:CGIXCancer Genetics Inc
26/02/202118:51Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:CGIXCancer Genetics Inc
16/02/202118:45GlobeNewswire Inc.Cancer Genetics Announces Closing of $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq RulesNASDAQ:CGIXCancer Genetics Inc
11/02/202101:00GlobeNewswire Inc.Cancer Genetics Announces $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq RulesNASDAQ:CGIXCancer Genetics Inc
08/02/202118:56Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CGIXCancer Genetics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:CGIX

Seu Histórico Recente

COIN
SUSHUSD
Super shiba coin
BIT
I08814
Intesa Sanpaolo
NASDAQ
AAXOGXX
Hsbc Bank Usa Na Point t...
BIT
S27189
Societe Generale Effekten
NYSE
STI-A
SunTrust Banks
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados